{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T20:03:14Z","timestamp":1768766594642,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejpb.2018.11.015","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T17:05:27Z","timestamp":1542647127000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Pharmacokinetics of topically applied tacrolimus dissolved in Marinosolv, a novel aqueous eye drop formulation"],"prefix":"10.1016","volume":"134","author":[{"given":"Cornelia","family":"Siegl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marielle","family":"K\u00f6nig-Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Nakowitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Koller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Graf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Unger-Manhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Schindlegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman","family":"Kirchoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Knecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Prieschl-Grassauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.11.015_b0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tjo.2015.03.004","article-title":"Immunosuppressive therapy for eye diseases: effectiveness, safety, side effects and their prevention","volume":"5","author":"Hornbeak","year":"2015","journal-title":"Taiwan J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.11.015_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40662-017-0072-z","article-title":"Topical tacrolimus in anterior segment inflammatory disorders","volume":"4","author":"Shoughy","year":"2017","journal-title":"Eye Vis. (Lond)"},{"key":"10.1016\/j.ejpb.2018.11.015_b0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0896-1549(02)00023-8","article-title":"Corticosteroids in uveitis","volume":"15","author":"Rothova","year":"2002","journal-title":"Ophthalmol. Clin. North Am."},{"key":"10.1016\/j.ejpb.2018.11.015_b0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0301-4738.114099","article-title":"Medical management of uveitis \u2013 current trends","volume":"61","author":"Babu","year":"2013","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.11.015_b0025","first-page":"465","article-title":"Treating ocular surface disease: new agents in development","volume":"5","author":"Fahmy","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.11.015_b0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/aos.12675","article-title":"Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization","volume":"93","author":"Lloren\u00e7","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.11.015_b0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0731-7085(95)01605-8","article-title":"Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography","volume":"14","author":"Akashi","year":"1996","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"Pt 3","key":"10.1016\/j.ejpb.2018.11.015_b0040","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/eye.1991.46","article-title":"Use of steroids and immunosuppressive drugs in the management of posterior uveitis","volume":"5","author":"Lightman","year":"1991","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ejpb.2018.11.015_b0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/jop.2011.0108","article-title":"Ocular safety and pharmacokinetics study of FK506 suspension eye drops after corneal transplantation","volume":"28","author":"Yuan","year":"2012","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2018.11.015_b0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jop.2008.0125","article-title":"Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration","volume":"25","author":"Yuan","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2018.11.015_b0055","first-page":"17","article-title":"The oral dosage form of FK-506","volume":"19","author":"Honbo","year":"1987","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ejpb.2018.11.015_b0060","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jps.1025","article-title":"Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats","volume":"90","author":"Arima","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.11.015_b0065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijpharm.2012.01.054","article-title":"Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-\u03b2-cyclodextrin inclusion complex-loaded albumin nanoparticles","volume":"427","author":"Gao","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.11.015_b0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12272-014-0343-3","article-title":"Bioequivalence of tacrolimus formulations with different dynamic solubility and in-vitro dissolution profiles","volume":"38","author":"Kwon","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.11.015_b0075","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ejps.2012.12.001","article-title":"Some transformations of tacrolimus, an immunosuppressive drug","volume":"48","author":"Skytte","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.11.015_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.05.056","article-title":"For the special IJP issue \u201cPoorly soluble drugs\u201d","volume":"453","author":"Loftsson","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.11.015_b0085","first-page":"275","article-title":"Increased uptake of lipophilic immunosuppressive compounds in cornea and retina based on solubilization in an aqueous formulation","volume":"57","author":"Nakowitsch","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2018.11.015_b0090","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3390\/ijerph10093834","article-title":"Optimal method to stimulate cytokine production and its use in immunotoxicity assessment","volume":"10","author":"Ai","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.ejpb.2018.11.015_b0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/2229-5186.79345","article-title":"Methods for the determination of limit of detection and limit of quantitation of the analytical methods","volume":"2","author":"Shrivastava","year":"2011","journal-title":"Chron Young Sci."},{"key":"10.1016\/j.ejpb.2018.11.015_b0100","series-title":"Methods Of Dealing With Values Below The Limit Of Detection Using SAS","author":"Croghan","year":"2003"},{"key":"10.1016\/j.ejpb.2018.11.015_b0105","unstructured":"B. Magnusson, U. \u00d6rnemark, Eurachem Guide: The Fitness for Purpose of Analytical Methods \u2013 A Laboratory Guide to Method Validation and Related Topics, (2nd ed. 2014), http:\/\/www.eurachem.org."},{"key":"10.1016\/j.ejpb.2018.11.015_b0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13567-014-0113-8","article-title":"Cytokine profiles in pregnant gilts experimentally infected with porcine reproductive and respiratory syndrome virus and relationships with viral load and fetal outcome","volume":"45","author":"Ladinig","year":"2014","journal-title":"Vet. Res."},{"key":"10.1016\/j.ejpb.2018.11.015_b0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1600-0420.2002.800205.x","article-title":"Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye","volume":"80","author":"Loftsson","year":"2002","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.ejpb.2018.11.015_b0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/dta.112","article-title":"An improved validated ultra high pressure liquid chromatography method for separation of tacrolimus impurities and its tautomers","volume":"2","author":"Subasranjan","year":"2010","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.ejpb.2018.11.015_b0125","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2146\/ajhp160169","article-title":"Stability of tacrolimus ophthalmic solution","volume":"74","author":"Ezquer-Garin","year":"2017","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ejpb.2018.11.015_b0130","first-page":"119","article-title":"Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers","volume":"49","author":"Taormina","year":"1992","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/j.ejpb.2018.11.015_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031465","article-title":"Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of na\u00efve T cells into cytokine-producing mature T cells","volume":"7","author":"Tsuda","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2018.11.015_b0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2332\/allergolint.11-OA-0349","article-title":"Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension","volume":"61","author":"Ebihara","year":"2012","journal-title":"Allergol. Int."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118309524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118309524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T15:08:02Z","timestamp":1720796882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118309524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":28,"alternative-id":["S0939641118309524"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.015","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of topically applied tacrolimus dissolved in Marinosolv, a novel aqueous eye drop formulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}